Icotrokinra Achieves Complete Skin Clearance Through Week 52 in Trials
Oral peptide icotrokinra delivered complete skin clearance through week 52 with a strong safety profile in the ICONIC-ADVANCE trials, presented at the American Academy of Dermatology meeting.